Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Kovsie student translates and interprets between English and Mandarin
2012-11-14

Chen-Shu
14 November 2012

When television channel e.tv recently interviewed successful Chinese businesspersons in South Africa and Tanzania, they turned to Kovsie student Chen-Shu Fang to translate from English into Mandarin. Chen-Shu, who has completed a BA Honours in Linguistics, is the first student in the Department of Linguistics and Language Practice translating and interpreting between English and Mandarin.

Born in Taiwan, Chen-Shu started her high-school education in South Africa in 1997 and matriculated in 2001. She completed a Bachelor’s degree in Taiwan, but returned to South Africa in 2011, enrolling for studies in the Department of Linguistics and Language Practice. After completing her honours degree in June 2012, Chen-Shu decided to also enrol for the practical honours module in Translation Studies in preparation of her Master’s degree next year.

“I have some background knowledge in linguistics, but during my studies at the UFS, I discovered an interest in interpreting and translation. Therefore, I changed my main focus from Linguistics to Language Practice,”says Chen-Shu.

This year, Chen-Shu also started offering translation and interpretation services. Her first interpreting brief from the Unit for Language Facilitation and Empowerment (ELFE) at the UFS was for Dairy Belle where she had to interpret for a technician from China. She furthermore assists in the translation of the website of Hsiang Chun Orchid Garden, a Bloemfontein-based company (www.hcorchids.co.za).

“I have a great interest in translation, and would also like to offer my language skills and knowledge gained in this course to the Mandarin-speaking community in Bloemfontein. This degree has given me the opportunity to practise and enhance the necessary language practice skills. ”

On assessing Chen-Shu’s translations, an external marker for Mandarin from Rhodes University commented as follows on our department’s course: “I am impressed by your generous and relaxed attitude towards such a diverse group of students, so that they can actually follow a translation course and develop translation skills within their own, unique context”.

 

 


 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept